Gapping down
In reaction to earnings/guidance:
- CHGG -43.2%, ETWO -24.4%, TREE -19.9%, CYH -13.6%, ANET -9.2%, CACC -6.8%, CNO -6.3%, ZBRA -6.3%, BP -5.2%, DD -4.9%, SCI -3.8%, SYK -3.7%, CAR -3.4%, RGEN -3.2%, ADUS -3.1%, BRX -3.1%, RE -3%, FMC -3%, FWRD -2.5%, INMD -2.4%, AXNX -2.3%, MED -2%, FANG -2%, KIDS -1.9%, TRTN -1.9%, INCY -1.8%, RMBS -1.7%, OGS -1.7%, SYM -1.6%, MDC -1.6%, RYTM -1.6%, LDOS -1.4%, TRI -1.3%, VRTX -1.2%, AQUA -1.2%, JJSF -1%, LGIH -1%, BSM -0.9%, HOLX -0.8%, MGM -0.8%
Other news:
- TVTX -23.7% (topline primary efficacy results from Phase 3 DUPLEX study)
- ADSE -5.3% (delaying filing 20-F)
- ACT -3% (increases dividend)
- MLTX -2.9% (files mixed shelf)
Analyst comments:
- SHLS -4.3% (downgraded to Underweight from Equal Weight at Barclays)
- SOFI -3.7% (downgraded to Neutral from Outperform at Wedbush)
- CPRI -2.1% (downgraded to Equal Weight from Overweight at Barclays)
- COIN -1.5% (downgraded to Neutral from Buy at Citigroup)
- DGX -1.4% (downgraded to Neutral from Buy at BofA Securities)
- CHKP -1.1% (downgraded to Neutral from Buy at BTIG Research)
- WD -1.1% (downgraded to Mkt Perform from Mkt Outperform at JMP Securities)
